首页> 外国专利> Preparation method of a Transdermal Delivery device.Transdermal Delivery device and use of a steroid comoaditivo in a Transdermal Delivery device

Preparation method of a Transdermal Delivery device.Transdermal Delivery device and use of a steroid comoaditivo in a Transdermal Delivery device

机译:透皮递送装置的制备方法透皮递送装置和类固醇comoaditivo在透皮递送装置中的用途

摘要

Method of preparing a transdernal Management device, Management device and a transdernal steroid as an Additive in transdernal Administration.The Method of preparation of the nistracion transdernal bythe Management Device includes the steps of: (a) preparacionde mixture at leastA First combination of Hormone or Hormones in an amount sufficient to produce a therapeutic effect during use and materialesque Scheme are the Matrix in which DecHas First Hormone or combination of hormones is Distributed, (b) Provision of mix in or on a bracket to form a Matrix containing the first Hormone or combination dehormonas,(c) the mixture lusion Inc in 2000 as a steroidTaking this as an effect of inhibiting the crystallization of the first Hormone or combination of hormonasal store the full devicePeroestando Said steroid and in an amount insufficient to cause a Physiological effect terapu00e9uticosignificativo or when the device is used.Transdermal Delivery device is composed of a material Body and unsoporte to itHold Down The Body of the material, a First combination of Hormone or Hormones in an amount sufficient to cause an effect terapu00e9uticocuando device is used, andAs inhibitor of the first crystallization of co combination of hormones or hormone, a steroid, which is present in an amount greater than that normally exists as an impurity.But enough to cause some pharmacological or terapu00e9uticosignificativocuando device is used.The use of a steroid as Additive in the Manufacturing process of a transdernal acting device
机译:制备经皮管理装置的方法,管理装置和经皮类固醇作为经皮给药的添加剂。用该管理装置制备鼻虫经皮的方法包括以下步骤:(a)杀虫前混合物至少一种激素或激素的第一组合足以在使用和使用中达到治疗效果的量的配方是散布DecHas第一激素或激素组合的基质,(b)在支架内或支架上提供混合物以形成包含第一激素或组合的基质dehormonas,(c)2000年混合物lusion Inc作为类固醇采取此措施是为了抑制第一个激素或激素组合的结晶,从而将整个装置储存在整个装置中。所述类固醇的量不足以引起生理效应terap u00e9uticosignificativo或当使用该设备时。透皮递送设备由材料主体和按住该材料的主体,使用一种或多种激素的第一种组合,其用量足以引起terap u00e9uticocuando装置的作用,并且作为激素或激素,类固醇的第一种共结晶的抑制剂。的存在量大于通常以杂质形式存在的量。但是足以引起某些药理学或萜烯的使用。类固醇作为添加剂在透皮作用器械的制造过程中的使用

著录项

  • 公开/公告号AR013520A1

    专利类型

  • 公开/公告日2000-12-27

    原文格式PDF

  • 申请/专利权人 ETHICAL PHARMACEUTICALS SOUTH AMERICA S.A.;

    申请/专利号AR1998P104789

  • 发明设计人

    申请日1998-09-25

  • 分类号A61K31/56;A61K47/28;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号